JAGUAR HEALTH, INC. COMMON STOCK WARRANTJaguar Health, Inc. • April 4th, 2019 • Pharmaceutical preparations • Delaware
Holder is an “Accredited Investor” as that term is defined in Regulation D promulgated by the Securities and Exchange Commission. The term “Accredited Investor” under Regulation D refers to:
LETTER OF CREDIT CANCELLATION & WARRANT ISSUANCE AGREEMENTWarrant Issuance Agreement • April 4th, 2019 • Jaguar Health, Inc. • Pharmaceutical preparations • California
THIS LETTER OF CREDIT CANCELLATION & WARRANT ISSUANCE AGREEMENT (the “Agreement”) is deemed to be effective as of March 29, 2019 (the “Effective Date”), by and among Jaguar Health, Inc., a Delaware corporation (the “Company”), and the undersigned letter of credit beneficiary identified on the signature page hereto (the “LC Beneficiary”).
